title: Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effects.
authors.affiliation: Pediatric Nephrology, Children's and Adolescents' Hospital, University Hospital, Cologne, Germany. soeren.baeumner@uk-koeln.de.
authors.forename: Sören
authors.initials: S
authors.lastname: Bäumner
authors.affiliation: Pediatric Nephrology, Children's and Adolescents' Hospital, University Hospital, Cologne, Germany.
authors.forename: Lutz T
authors.initials: LT
authors.lastname: Weber
mesh_terms: D003543:Cysteamine; D003554:Cystinosis; D005198:Fanconi Syndrome; D006801:Humans; D012189:Retrospective Studies
chemical_list: D003543:Cysteamine